Citizens Financial Group Inc. RI Makes New $276,000 Investment in GE HealthCare Technologies Inc. $GEHC

Citizens Financial Group Inc. RI acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,729 shares of the company’s stock, valued at approximately $276,000.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its stake in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the period. Nuveen LLC acquired a new stake in GE HealthCare Technologies in the first quarter worth $77,058,000. Eminence Capital LP grew its holdings in GE HealthCare Technologies by 38.7% in the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after purchasing an additional 507,101 shares during the period. Canada Pension Plan Investment Board increased its stake in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Mizuho Markets Cayman LP acquired a new position in shares of GE HealthCare Technologies during the second quarter valued at about $29,628,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 1.8%

GEHC stock opened at $72.31 on Thursday. The stock has a 50-day simple moving average of $74.77 and a two-hundred day simple moving average of $73.76. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market capitalization of $32.94 billion, a PE ratio of 14.94, a PEG ratio of 2.97 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were given a $0.035 dividend. The ex-dividend date was Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price target for the company. BTIG Research set a $87.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, October 29th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Finally, Evercore ISI upped their target price on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.